Amgen to Acquire Onyx for $10.4 Billion

August 26, 2013

Biotech giant Amgen Inc. said it has reached a $10.4-billion deal for cancer drug maker Onyx Pharmaceuticals Inc., the Los Angeles Times reports.

No items found.